TRD occurs in individuals suffering from major depression who fail to respond to initial antidepressant treatments. AXS-05 is a novel, oral, investigational drug product, incorporating multiple mechanisms of action, under development for the treatment of TRD.
Learn more about TRD and AXS-05Individuals diagnosed with Alzheimer’s Disease typically experience behavioral and psychological symptoms including agitation and aggression. AXS-05 is a novel, oral, investigational drug product, incorporating multiple mechanisms of action, under development for the treatment of Alzheimer’s disease agitation.
Learn more about Agitation Associated With Alzheimer's Disease and AXS-05